Evidence map›Paper›PMID 19500151›Full record

ArticleGenes, brain, and behavior2009

Heroin addiction in African Americans: a hypothesis-driven association study.

O Levran, D Londono, K O'Hara, M Randesi, J Rotrosen, P Casadonte, S Linzy, J Ott, M Adelson, M J Kreek

Abstract read
In one paragraph

Article in Genes, brain, and behavior, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Article
  3. Genetic and Epigenetic Approaches to Opioid Use Disorder.Expert reviews in molecular medicine · 2025
    Review
  4. Article
  5. Biochemical Diagnosis in Substance and Non-substance Addiction.Advances in experimental medicine and biology · 2025
    Review
  6. Review
  7. SNP analysis of stress-related genes reveals significant correlations with drug addiction in Jordan.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. VMAT2 gene (Pharmacogenomics · 2019
    Article
  17. Review
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

O LevranThe Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA. levrano@rockefeller.edu
D Londono
K O'Hara
M Randesi
J Rotrosen
P Casadonte
S Linzy
J Ott
M Adelson
M J Kreek
Rockefeller University · USVA NY Harbor Healthcare System · USBeijing Institute of Genomics · CN

Funding

ULTRASTUCTURE, RECEPTORS, AND GENE EXPRESSIONP60DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 2002 to 2012
$30.6M
LINKAGE ANALYSIS METHODS IN SCHIZOPHRENIAR01MH044292 · NIMH · ROCKEFELLER UNIVERSITY · PI OTT, JURG · 1989 to 2008
$1.3M
Addictive Drugs-Pharmacology &PhysiologyK05DA000049 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 1985 to 2007
$1.0M
NIDA NIH HHS K05 DA000049NIDA NIH HHS P60 DA005130NIMH NIH HHS R01 MH044292PHS HHS K05-00049PHS HHS P60-05130PHS HHS R01-44292
6 · The paper itself

Abstract

Heroin addiction is a chronic complex disease with a substantial genetic contribution. This study was designed to identify gene variants associated with heroin addiction in African Americans. The emphasis was on genes involved in reward modulation, behavioral control, cognitive function, signal transduction and stress response. We have performed a case-control association analysis by screening with 1350 variants of 130 genes. The sample consisted of 202 former severe heroin addicts in methadone treatment and 167 healthy controls with no history of drug abuse. Single nucleotide polymorphism (SNP), haplotype and multi-SNP genotype pattern analyses were performed. Seventeen SNPs showed point-wise significant association with heroin addiction (nominal P< 0.01). These SNPs are from genes encoding several receptors: adrenergic (ADRA1A), arginine vasopressin (AVPR1A), cholinergic (CHRM2), dopamine (DRD1), GABA-A (GABRB3), glutamate (GRIN2A) and serotonin (HTR3A) as well as alcohol dehydrogenase (ADH7), glutamic acid decarboxylase (GAD1 and GAD2), the nucleoside transporter (SLC29A1) and diazepam-binding inhibitor (DBI). The most significant result of the analyses was obtained for the GRIN2A haplotype G-A-T (rs4587976-rs1071502-rs1366076) with protective effect (P(uncorrected) = 9.6E- 05, P(corrected) = 0.058). This study corroborates several reported associations with alcohol and drug addiction as well as other related disorders and extends the list of variants that may affect the development of heroin addiction. Further studies will be necessary to replicate these associations and to elucidate the roles of these variants in drug addiction vulnerability.

Indexed as

AdultBlack or African AmericanBrain ChemistryCase-Control StudiesDNA Mutational AnalysisEnzymesFemaleGenetic Predisposition to DiseaseGenetic TestingGenotypeHaplotypesHeroin DependenceHumansMaleNerve Tissue ProteinsPolymorphism, Single NucleotideEnzymesNerve Tissue ProteinsReceptors, NeurotransmitterReceptors, N-Methyl-D-Aspartate

Identifiers

PMID19500151
PMCPMC2716061
OpenAlexW2058673913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.